This FREE interactive event focuses on building trustworthiness in clinical research. One powerful structural solution to inclusive clinical trials is their delivery in Federally Qualified Health Centers (FQHCs) and safety-net facilities. We will focus on successful examples and partnership opportunities for ongoing cancer trials for oncology patients with breast cancer, prostate cancer, lung cancer and HIV. Our conversation will include diverse perspectives, including patients, community partners, providers and pharmaceutical partners.
This is the third of five panel discussions on StructurAl SolutionS for DivErse Cancer TrialS (ASSETS) for Cook County Series.
If you are unable to attend this in-person event, please check our website for more information on a December webinar.
Welcome and Opening Remarks
“The Value of Clinical Trials in FQHC and Safety Net Facilities: Patient and Clinical Trial Participant Perspectives”
This diverse panel of patients and cancer survivors will speak to their experiences participating in clinical trials and partnering in clinical research. They will highlight the value of trustworthy research, especially when offered within trusted FQHC and safety-net settings.
“The Infrastructure of Clinical Trials in FQHC and Safety-Net Facilities: Administrative Leaders and Sponsor Perspectives”
This diverse panel of administrative leaders and pharmaceutical partners will highlight best practices and emerging opportunities for investing in clinical research at FQHCs and safety-net settings to address diversity in clinical trial participation.
“Feasibility of Trials in FQHC and Safety-Net Settings and Ongoing Trials”
These breakout rooms will highlight the logistics and feasibility of engaging in clinical research in FQHC and safety-net settings. They also will provide a venue for discussion on partnerships and ongoing trials for these specific health priorities: lung, breast and prostate cancer trials and cancer trials for patients living with HIV and cancer.